Syverson Strege & Co’s ResMed RMD Stock Holding History

Syverson Strege & Co’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-27	Closed	-$7K	–	329
2021 Q4	$7K	Hold	27	–	–	0.01%	223
2021 Q3	$7K	Hold	27	–	–	0.01%	287
2021 Q2	$7K	Buy	+27	New	+$5.68K	0.01%	215

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

OCBV

Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return

Syverson Strege & Co's RMD Position: Q1 2022 in Review

Syverson Strege & Co sold out of ResMed (RMD) in Q1 2022, closing a stake of 27 shares — an estimated $7K sold.

Syverson Strege & Co first reported a position in RMD in Q2 2021 and held it in 3 quarters. The position peaked at $7K in Q4 2021. 682 funds tracked by Wall St. Rank hold RMD as of Q1 2022.

Syverson Strege & Co reported no remaining ResMed position as of Q1 2022 after selling out during the quarter.
Syverson Strege & Co sold 27 ResMed shares in Q1 2022, an estimated $7K.
Syverson Strege & Co first reported a position in ResMed in Q2 2021 and held it in 3 quarters.
Syverson Strege & Co's ResMed position peaked at $7K in Q4 2021.
682 funds tracked by Wall St. Rank held ResMed as of Q1 2022.

Based on Syverson Strege & Co's 13F filing for Q1 2022, filed 13 Apr 2022.